ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,384,855, issued on Aug. 12, was assigned to KYMAB Ltd. (Cambridge, Great Britain).
"PCSK9 antagonists" was invented by Allan Bradley (Cambridge, Great Britain), Qi Liang (Cambridge, Great Britain), E-Chiang Lee (Cambridge, Great Britain), Li-Ying Liou (Xinyi District Taipei, Taiwan), Yu-Hui Huang (Xinyi District Taipei, Taiwan), Yen-Ju Chen (Xinyi District Taipei, Taiwan) and Li-Tzu Chen (Xinyi District Taipei, Taiwan).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to Proprotein Convertase Subtilisin Kexin type 9 (PCSK9) antagonists, such as antibodies and fragments, as well as methods, uses and combinations."
The patent was filed ...